{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Don\u2019t forget the toes: Managing patients with ANCA vasculitis","description":" Active or not active, that is the question. In this week's episode we interview&amp;nbsp;Alexandra Villa-Forte, MD, MPH, a staff physician in the Center for Vasculitis Care and Research at Cleveland Clinic and a leading vasculitis expert, on a pragmatic approach to recognizing disease activity in patients with ANCA vasculitis.   \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Intro 0:01  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Welcome Alexandra Villa-Forte,&amp;nbsp;MD, MPH 0:10  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Dr. Brown sketches a potential patient that may be seen in practice 0:40  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; How are you monitoring patients\u2019 kidneys? 1:28  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; How reliable are \u2018no casts\u2019 results in urinalysis tests? 4:15  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; What is happening in the glomeruli? 5:23  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; The importance of monitoring the urinalysis of patients with ANCA vasculitis 7:06  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Symptoms to watch for when tapering off medications 7:43  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Different scenarios with lung symptoms 9:35  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Evaluating patients with GPA; looking at the nose, ear and sinuses 12:20  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Neurologic symptoms in ANCA vasculitis 14:24  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Laboratory monitoring 15:52  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Should ANCA titers be a part of routine vasculitis monitoring? 17:05  \u00b7&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; What is your approach using PJP prophylaxis in ANCA-associated vasculitis? 18:05  Thank you, Dr. Villa-Forte! 20:25  We\u2019d love to hear from you! Send your comments\/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. &amp;nbsp;   Disclosures: Brown reports no relevant financial disclosures. Healio was&amp;nbsp;unable&amp;nbsp;to&amp;nbsp;confirm&amp;nbsp;relevant financial&amp;nbsp;disclosures for Villa-Forte&amp;nbsp;at the time of publication. ","author_name":"Healio Rheuminations","author_url":"http:\/\/rheuminations.healio.libsynpro.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/38397730\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/87A93A\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/193582515"}